Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tougeron

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Diagnostic and Interventional Imaging|October 20, 2022
Irreversible electroporation and electrochemotherapy in oncology: State of the artJean-Pierre Tasu, David Tougeron, Marie-Pierre Rols
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 11, 2017
Future perspectives of circulating tumor DNA in colorectal cancerC Nadal, T Winder, A Gerger, et al.
Expert Opinion on Biological Therapy|February 24, 2018
Results and challenges of immune checkpoint inhibitors in colorectal cancerSheik Emambux, Gaelle Tachon, Audelaure Junca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2013
Aspirin and colorectal cancer: back to the futureDavid Tougeron, Dan Sha, Sashidhar Manthravadi, et al.
Cancers|July 24, 2021
Endoscopy to Diagnose and Prevent Digestive Cancers in Lynch SyndromeRaphael Olivier, Violaine Randrian, David Tougeron, et al.
World Journal of Gastrointestinal Oncology|August 26, 2015
Anti program death-1/anti program death-ligand 1 in digestive cancersEléonore de Guillebon, Pauline Roussille, Eric Frouin, et al.
Plos One|June 1, 2013
MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cellsJae Myung Park, Shengbing Huang, David Tougeron, et al.
Cancers|October 18, 2019
Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal CancerCamille Evrard, Gaëlle Tachon, Violaine Randrian, et al.
Plos One|June 24, 2014
Beclin 1 and UVRAG confer protection from radiation-induced DNA damage and maintain centrosome stability in colorectal cancer cellsJae Myung Park, David Tougeron, Shengbing Huang, et al.
Therapeutic Advances in Gastroenterology|March 16, 2026
Analysis of diagnostic pathway and therapeutic delay for patients with pancreatic adenocarcinoma: a French retrospective studyCamille Evrard, Bérénice Vauchel, Claire Boyer, et al.
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Diagnostic and Interventional Imaging|October 20, 2022
Irreversible electroporation and electrochemotherapy in oncology: State of the artJean-Pierre Tasu, David Tougeron, Marie-Pierre Rols
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 11, 2017
Future perspectives of circulating tumor DNA in colorectal cancerC Nadal, T Winder, A Gerger, et al.
Expert Opinion on Biological Therapy|February 24, 2018
Results and challenges of immune checkpoint inhibitors in colorectal cancerSheik Emambux, Gaelle Tachon, Audelaure Junca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2013
Aspirin and colorectal cancer: back to the futureDavid Tougeron, Dan Sha, Sashidhar Manthravadi, et al.
Cancers|July 24, 2021
Endoscopy to Diagnose and Prevent Digestive Cancers in Lynch SyndromeRaphael Olivier, Violaine Randrian, David Tougeron, et al.
World Journal of Gastrointestinal Oncology|August 26, 2015
Anti program death-1/anti program death-ligand 1 in digestive cancersEléonore de Guillebon, Pauline Roussille, Eric Frouin, et al.
Plos One|June 1, 2013
MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cellsJae Myung Park, Shengbing Huang, David Tougeron, et al.
Cancers|October 18, 2019
Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal CancerCamille Evrard, Gaëlle Tachon, Violaine Randrian, et al.
Plos One|June 24, 2014
Beclin 1 and UVRAG confer protection from radiation-induced DNA damage and maintain centrosome stability in colorectal cancer cellsJae Myung Park, David Tougeron, Shengbing Huang, et al.
Therapeutic Advances in Gastroenterology|March 16, 2026
Analysis of diagnostic pathway and therapeutic delay for patients with pancreatic adenocarcinoma: a French retrospective studyCamille Evrard, Bérénice Vauchel, Claire Boyer, et al.
Pageof 24